Repurposing metformin: another possible bullet to target cheaply ulcerative colitis

Puntos clave

• Findings indicate that metformin may reduce inflammation markers in ulcerative colitis.
• Key evidence shows a significant improvement in symptoms among 40 participants over 12 weeks.
• Analysis of treatment using metformin demonstrates its potential impact on ulcerative colitis pathways.
• This suggests metformin may become a viable low-cost option for managing ulcerative colitis.